IM8 Health: Live Ad Intelligence
Every active IM8 ad, pulled from the public Meta Ad Library and mapped by angle, awareness, format and channel, with the whitespace where fresh creative would move fastest.
Snapshot
100
active ads mapped
10
distinct angles
18.8d vs 8.9d
publisher-native vs brand-direct avg lifespan
33d
longest-running ad
The read
What the account is telling us
- IM8 runs a mature, multi-angle account: 100 active ads across 10 angles and 4 channel types (brand-direct, publisher-native, creator/athlete, doctor). They've clearly invested in breadth.
- The durable winners are publisher-native editorials. Controlling for the obvious variable, format barely moves longevity (static 11.0d vs video 10.6d). Channel is what predicts staying power: publisher-native ads average 18.8 days live vs 8.9 for brand-direct, over 2x. Of the 16 ads running 20+ days, 15 are publisher-native editorial.
- That means their durable spend rides on a small bench of editorial concepts, while brand-direct creative fatigues in ~9 days. It's a volume-of-fresh-editorial dynamic, the exact category that warms cold traffic and lasts.
- The account skews product-aware (64/100), most ads already assume you know IM8. The problem-aware top-of-funnel (29/100) that warms strangers is comparatively light, with no solution-aware bridge in between.
- They've built dedicated landing pages per angle (menopause, glp1, skin, gut, focus, joints, energy). That's strong funnel infrastructure, and a few pages are ready to absorb more creative than currently points at them. Where a page doesn't exist yet, we build the advertorial too, so the ad and the page ship as one congruent unit, not a handoff between two vendors.
Angle landscape
What they're running, by angle
Share of active ads by angle. Broad coverage, but lopsided, and a couple of angles have a dedicated landing page with almost no ads pointed at it.
What's winning
Longest-running creative = our best free proxy for spend
We can't see spend, CTR or ROAS (not public), but how long an ad has run is the strongest free signal of what's working. The clear pattern is channel, not format.
The longest-running individual ads, de-duplicated by angle & channel:
no preview
(image n/a)
(image n/a)
no preview
(image n/a)
(image n/a)
no preview
(image n/a)
(image n/a)
Their durable spend rides on a small bench of publisher-native editorial concepts (15 of the 16 ads live 20+ days). Brand-direct creative fatigues in ~9 days. That's a volume-of-fresh-editorial dynamic, and editorial, ad-to-page, is precisely the lane we build in.
Where the clicks go
The funnel behind the ads
The destination URL on every ad reveals the funnel, and it's the layer you can't see by glancing at the Ad Library. IM8 is already sophisticated about ad-to-page matching; the gaps are specific.
57
routed to dedicated /pages landing pages
38
routed straight to the /products PDP
2
creator ads routed to an Instagram profile (no buy path)
- Well-fed: /menopause (13 ads), /skin-health (5), /gut-health (3). Tight ad-to-page matching here.
- Starved pages: /focus, /joints and /energy each have a dedicated page but only 1 ad pointing at it. The funnel exists; the creative to feed it doesn't yet.
- Three competing GLP-1 pages: /pages/glp1 (10 ads), /im8-landing-page-GLP1 (7), /glp1-strength-lp (1). Split testing or fragmentation. Either way, there's room to consolidate the winning ad-to-page pair.
- Open buy-path gap: 2 creator ads route to an Instagram profile instead of a buy path.
Angle × awareness
Where the coverage is, and where it isn't
Each ad mapped to the reader's awareness stage (inferred from how the copy opens). Deep green = saturated; pale = whitespace.
| Problem-aware | Solution-aware | Product-aware | Most-aware | |
|---|---|---|---|---|
| All-in-one / Replace-the-stack | 2 | 27 | 3 | |
| GLP-1 support | 10 | 8 | ||
| Menopause/Perimenopause | 4 | 9 | ||
| Gut/Mood/Sleep | 4 | 4 | ||
| Athlete/Performance | 7 | 1 | ||
| Skin/Collagen | 4 | 4 | ||
| Longevity/Beckham Stack | 1 | 2 | 3 | |
| Aging (After-30 decline) | 3 | 2 | ||
| Safety/Testing | 1 | |||
| Joints | 1 |
whitespace (0)saturatedAwareness inferred from copy framing, directional, not exact.
Format mix
Static
57
Video/UGC
43
Channel mix
Brand-direct
60
Publisher-native
24
Creator/Athlete
14
Doctor-authority
2
Opportunity map
Where fresh creative could move fastest
Not a critique of what's running. It's working. These are the under-built cells, each framed as a testable hypothesis with a starting scope. Every one is an on-brand editorial-volume play.
1
Feed the starved landing pages
Dedicated pages for Focus, Joints and Energy are live with ~1 ad each. Hypothesis: these are real demand pockets already validated enough to build a page for; problem-aware editorials pointed at them convert because the page is already congruent. We can build the ads and extend the pages where needed.
3 problem-aware editorials per page
2
Widen the GLP-1 angle
18 GLP-1 ads and a proven core script already validated. Hypothesis: GLP-1 buyers split across distinct sub-pains (nausea, plateau, muscle loss, ‘thinner but feel worse’). Distinct problem-aware editorials per sub-pain expand reach on top of what's working, and give the 3 GLP-1 pages a cleaner ad-to-page pair.
6 distinct GLP-1 editorial angles
3
Deepen the bench behind the winning format
Publisher-native editorial is the proven durable format. Hypothesis: the limiter on that channel is concept supply, not concept quality, each new editorial concept in the proven format stacks on a known-good template and reduces reliance on a small set of long-runners.
5 fresh editorial concepts
4
Build the problem-aware top-of-funnel
The account is strong on product-aware (64/100). It converts people who already know IM8. Hypothesis: a cold, problem-aware editorial layer (the part that warms a stranger before the pitch) is the biggest additive lever, especially for menopause and GLP-1.
problem-aware set, 4 angles
5
Scale the safety / testing story
The NSF / heavy-metals-tested / ‘natural isn't safe’ angle appears in ~1–2 ads despite being a strong, underused trust differentiator vs cheaper supplements. Hypothesis: it earns its own editorial lane for skeptical, ingredient-literate buyers.
3 safety-led editorials
Five gaps. One kind of fix.
Every gap above is a fast, on-brand editorial-creative play, built ad-to-page congruent, on your mastheads, the format your own data shows lasts longest. Pick one cell and we'll ship a test set this week. No retainer to find out if it works.